Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

ARCT - Arcturus Therapeutics Holdings Inc.... | Finranks

Home

/

ARCT

A

Arcturus Therapeutics Holdings Inc. (ARCT)

NGM – Real Time Price. Currency in USD

7.58

+0.06 (0.81%)

Market open: Aug 12, 2026, 10:10 AM EDT

7.47

-0.05 (-0.66%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

67M

138M

158M

206M

Cost of goods sold

-3M

-4M

-3M

-

Gross Profit

64M

135M

155M

-

Operating expenses (excl. COGS)

-139M

-174M

-159M

-187M

Operating Income

-75M

-39M

-4M

17M

Non-operating income, total

9M

-42M

-24M

-6M

Pretax income

-66M

-81M

-28M

11M

Equity in earnings

0

0

0

-515K

Taxes

0

4K

-2M

-1M

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-66M

-81M

-30M

9M

Discontinued operations

0

0

0

0

Net income

-66M

-81M

-30M

9M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

271M-21.2%

344M-19.9%

429M-4.7%

450M

Total current assets

241M

306M

387M

403M

Total non-current assets

30M

38M

43M

47M

Total liabilities

57M-44.6%

103M-31.7%

151M-16.2%

180M

Total current liabilities

36M

65M

82M

127M

Total non-current liabilities

21M

38M

69M

53M

Total equity

214M

241M

279M

270M

Total liabilities & shareholders' equities

271M

344M

429M

450M

Total debt

25M-12.4%

29M-5.5%

30M-68.1%

95M

Name

2025

2024

2023

2022

Cash from operating activities

-74M

-60M

-18M

32M

Cash from investing activities

-230K

-648K

-3M

-8M

Cash from financing activities

13M

5M

-24M

-3M

Free cash flow

-75M-23.4%

-60M-187.6%

-21M-186.5%

24M